Related Experiment Video
Updated: Jul 16, 2026

04:23
A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images
Published on: April 21, 2023
The thyroid nodule--evaluation and management
Subhankar Chowdhury1, Satinath Mukherjee, Sarmistha Mukhopadhyay
1Department of Endocrinology and Metabolism, IPGME&R and SSKM Hospital, Kolkata.
Journal of the Indian Medical Association
|March 27, 2007
Summary
Thyroid nodules are common and often cause anxiety. A systematic diagnostic approach using TSH assays, ultrasound, and fine needle aspiration biopsy helps rule out malignancy and guide treatment for thyroid nodules.
Area of Science:
- Endocrinology
- Oncology
- Radiology
Background:
- Thyroid nodules are frequently diagnosed, necessitating evaluation to alleviate patient anxiety.
- Incidental thyroid nodules found during imaging for other conditions require assessment for malignancy.
Purpose of the Study:
- To outline a systematic approach for the diagnosis and management of thyroid nodules.
- To differentiate between benign and malignant thyroid nodules and guide appropriate treatment strategies.
Main Methods:
- Utilizing sensitive TSH assays as the initial investigation for thyroid nodules.
- Employing high-resolution ultrasonography (HRUSG) and ultrasound-guided fine needle aspiration biopsy (USG-FNA) for palpable nodules in euthyroid individuals.
- Recommending USG-FNA for nodules <10 mm only if suspicious clinical or USG features are present.
Main Results:
- Suppressed TSH levels indicate toxic nodules requiring radionuclide scans and FT4 assessment for management via radio-iodine or surgery.
- Elevated TSH levels prompt thyroid peroxidase antibody estimation.
- Benign nodules are managed with follow-up, while malignant nodules necessitate surgical removal.
- Cystic thyroid lesions can be effectively treated with percutaneous ethanol ablation.
Conclusions:
- A structured diagnostic pathway is crucial for managing thyroid nodules and reducing patient anxiety.
- Early and accurate diagnosis through imaging and biopsy guides the appropriate treatment, distinguishing benign from malignant conditions.
- Routine calcitonin and sub-cellular marker measurements are not recommended for thyroid nodule evaluation.
Related Concept Videos
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...